Skip to main content
Clinical Trials/NCT03863899
NCT03863899
Completed
Not Applicable

Pain Control With Ultrasound-guided Ilioinguinal Iliohypogastric Nerve Block Compared With Local Anesthesia Infiltration in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI): a Prospective, Randomized Trial

Medical University of Gdansk1 site in 1 country100 target enrollmentJuly 2, 2018

Overview

Phase
Not Applicable
Intervention
Nerve block
Conditions
Aortic Valve Stenosis
Sponsor
Medical University of Gdansk
Enrollment
100
Locations
1
Primary Endpoint
Numeric Rating Scale (NRS)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Ilioinguinal and iliohypogastric (ILIH) nerve blocks are frequently performed for analgesia in inguinal surgery.

The investigators hypothesized that preoperative ultrasound-guided ilioinguinal and iliohypogastric (ILIH) nerve blocks will produce better intraoperative analgesia and less analgesic requirement postoperatively in comparison to commonly used preoperative local infiltration anaesthesia for patients undergoing transfemoral transcatheter aortic valve implantation (TF-TAVI).

Detailed Description

It is a prospective, randomized trial. The patients will be randomized to one of the 2 groups: Group 1 - NERVE BLOCK. Ultrasound-guided ILIH nerve block will be performed by attending anaesthesiologist. Group 2 - LOCAL INFILTRATION. Local anaesthetic infiltration of the operative area will be performed by operator. During surgery patients will receive low-dose propofol infusion in order to achieve conscious sedation level, when indicated. An extra dose of local anaesthetic drug for infiltration of the surgical field or intravenous fentanyl or/and intravenous paracetamol will be given as rescue analgesics in patients reporting pain sensation. The patients will be observed for 24 hours. The pain at rest will be assessed using numeric rating scale (NRS 0 -10; 0 = no pain: 10 = max pain imaginable). On the first postoperative day intravenous analgesics will be given on demand (paracetamol 1 g iv (if NRS \<5) and oxycodone 2,5 mg iv (if NRS \> or = 5)).

Registry
clinicaltrials.gov
Start Date
July 2, 2018
End Date
December 31, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Liudmila Hasak, MD, PhD

Principal Investigator

Medical University of Gdansk

Eligibility Criteria

Inclusion Criteria

  • patients with aortic valve stenosis referred for TF-TAVI
  • using a minimalist approach of local anesthesia or nerve block with conscious sedation

Exclusion Criteria

  • patient's refusal to participate
  • allergy to local anaesthetic
  • TF-TAVI requiring general anesthesia or surgical cut-down
  • patients with major cognitive impairment and inability to assess their pain level in Numerical Rating Scale (NRS).

Arms & Interventions

Nerve block

ultrasound-guided ilioinguinal iliohypogastric nerve block performed by the anaesthesiologist for Transaortic valve implantation (TAVI) insertion with eventual additional intraoperative analgesia (AIA) and/or additional postoperative analgesia (APA)

Intervention: Nerve block

Nerve block

ultrasound-guided ilioinguinal iliohypogastric nerve block performed by the anaesthesiologist for Transaortic valve implantation (TAVI) insertion with eventual additional intraoperative analgesia (AIA) and/or additional postoperative analgesia (APA)

Intervention: TAVI

Nerve block

ultrasound-guided ilioinguinal iliohypogastric nerve block performed by the anaesthesiologist for Transaortic valve implantation (TAVI) insertion with eventual additional intraoperative analgesia (AIA) and/or additional postoperative analgesia (APA)

Intervention: Additional intraoperative analgesia

Nerve block

ultrasound-guided ilioinguinal iliohypogastric nerve block performed by the anaesthesiologist for Transaortic valve implantation (TAVI) insertion with eventual additional intraoperative analgesia (AIA) and/or additional postoperative analgesia (APA)

Intervention: Additional postoperative analgesia

Local infiltration

local anaesthesia infiltration performed by the operator for TAVI insertion with eventual intraoperative additional analgesia (AIA) and/or postoperative analgesia (APA)

Intervention: Local infiltration

Local infiltration

local anaesthesia infiltration performed by the operator for TAVI insertion with eventual intraoperative additional analgesia (AIA) and/or postoperative analgesia (APA)

Intervention: TAVI

Local infiltration

local anaesthesia infiltration performed by the operator for TAVI insertion with eventual intraoperative additional analgesia (AIA) and/or postoperative analgesia (APA)

Intervention: Additional intraoperative analgesia

Local infiltration

local anaesthesia infiltration performed by the operator for TAVI insertion with eventual intraoperative additional analgesia (AIA) and/or postoperative analgesia (APA)

Intervention: Additional postoperative analgesia

Outcomes

Primary Outcomes

Numeric Rating Scale (NRS)

Time Frame: 24 hours

The numeric rating scale will be used to determine the intraoperative and postoperative pain intensity levels of the patients. Pain intensity is scored 0-10 (0=no pain, 10=the worst pain imaginable). The pain intensity will be measured at 5 time points intraoperatively (femoral artery cannulation, aortic valve system introduction, aortic valve system removal, vessel closure devices insertion and the end of the operation) and at 2 time intervals postoperatively (0-12 hours and 12-24 hours).

Secondary Outcomes

  • Additional intraoperative analgesia consumption(24 hours)
  • Additional postoperative analgesia consumption(24 hours)
  • Patient satisfaction with analgesia(3 days)
  • Intraoperative and postoperative cost calculations(1 year)

Study Sites (1)

Loading locations...

Similar Trials